Ignite Creation Date:
2025-12-25 @ 5:03 AM
Ignite Modification Date:
2026-03-08 @ 1:06 AM
Study NCT ID:
NCT02335918
Status:
COMPLETED
Last Update Posted:
2019-12-09
First Post:
2014-12-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Dose Escalation and Cohort Expansion Study of Anti-CD27 (Varlilumab) and Anti-PD-1 (Nivolumab) in Advanced Refractory Solid Tumors
Sponsor:
Celldex Therapeutics
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-01
Start Date Type:
None
Primary Completion Date:
2018-12-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-12-12
Completion Date Type:
ACTUAL
First Submit Date:
2014-12-18
First Submit QC Date:
None
Study First Post Date:
2015-01-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2019-12-05
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2019-12-05
Last Update Post Date:
2019-12-09
Last Update Post Date Type:
ACTUAL